In a 19,114-person trial supported by the National Institutes of Health, researchers found that daily low-dose aspirin did not prolong independent living in healthy older adults.
Initial findings from the Aspree trial, which began in 2010, were published in The New England Journal of Medicine this week. The study involved participants who did not have dementia or a physical disability. Researchers followed the study’s participants for an average of 4.7 years to measure outcomes.
Get the full story at our sister site, Drug Delivery Business News.
